Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: An international multi-institutional analysis of 1669 patients

Annals of Surgery

Volumn 250, Issue 3, 2009, Pages 440-447

  De Jong, Mechteld C ^a   Pulitano, Carlo ^b   Ribero, Dario ^c   Strub, Jennifer ^d   Mentha, Gilles ^d   Schulick, Richard D ^a   Choti, Michael A ^a   Aldrighetti, Luca ^b   Capussotti, Lorenzo ^c   Pawlik, Timothy M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c MAURIZIANO HOSPITAL   (Italy)

^d UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL LIVER METASTASIS; FEMALE; HUMAN; LIVER METASTASIS; LIVER SURGERY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENCE RISK; REOPERATION; SURVIVAL RATE; SURVIVAL TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CATHETER ABLATION; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 70249110476     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181b4539b     Document Type: Article

References (41)

1. Howe HL, Wu X, Ries LA, et al. Annual report to the nation on the status of cancer 1975-2003, featuring cancer among US Hispanic/Latino populations. Cancer. 2006; 107:1711-1742.
2. Rudy DR, Zdon MJ. Update on colorectal cancer. Am Fam Physician. 2000;61:1759-1770, 1773-1774.
3. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10-30.
4. Berney T, Mentha G, Roth AD, et al. Results of surgical resection of liver metastases from non-colorectal primaries. Br J Surg. 1998;85:1423-1427.
5. Bismuth H, Adam R, Levi F, et al. Resection of nonresectable liver metas-tases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg. 1996;224:509-520; discussion 520-522.
6. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309-318; discussion 318-321.
7. Adson MA, van Heerden JA, Adson MH, et al. Resection of hepatic metastases from colorectal cancer. Arch Surg. 1984;119:647-651.
8. Pawlik TM, Schulick RD, Choti MA. Expanding criteria for resectability of colorectal liver metastases. Oncologist. 2008;13:51-64.
9. Gleisner AL, Choti MA, Assumpcao L, et al. Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation. Arch Surg. 2008;143:1204-1212.
10. Fortner JG, Silva JS, Golbey RB, et al. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer, I. Treatment by hepatic resection. Ann Surg. 1984;199:306-316.
11. Hughes KS, Rosenstein RB, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Dis Colon Rectum. 1988;31:1-4.
12. Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002; 235:759-766.
13. Pawlik TM, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metasta-ses. Ann Surg. 2005;241:715-722; discussion 722-724.
14. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239:818-825; discussion 825-827.
15. Fernandez FG, Drebin JA, Linehan DC, et al. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg. 2004;240:438-447; discussion 447-450.
16. Altendorf-Hofmann A, Scheele J. A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma. Surg Oncol Clin N Am. 2003;12:165-192, xi.
17. Sugihara K, Hojo K, Moriya Y, et al. Pattern of recurrence after hepatic resection for colorectal metastases. Br J Surg. 1993;80:1032-1035.
18. Yamada H, Kondo S, Okushiba S, et al. Analysis of predictive factors for recurrence after hepatectomy for colorectal liver metastases. World J Surg. 2001;25:1129-1133.
19. Fortner JG. Recurrence of colorectal cancer after hepatic resection. Am J Surg. 1988;155:378-382.
20. Steele G Jr, Osteen RT, Wilson RE, et al. Patterns of failure after surgical cure of large liver tumors. A change in the proximate cause of death and a need for effective systemic adjuvant therapy. Am J Surg. 1984;147:554-559.
21. Wagner JS, Adson MA, Van Heerden JA, et al. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg. 1984;199:502-508.
22. Bozzetti F, Doci R, Bignami P, et al. Patterns of failure following surgical resection of colorectal cancer liver metastases. Rationale for a multimodal approach. Ann Surg. 1987;205:264-270.
23. Ekberg H, Tranberg KG, Andersson R, et al. Pattern of recurrence in liver resection for colorectal secondaries. World J Surg. 1987;11:541-547.
24. Clavien PA, Emond J, Vauthey JN, et al. Protection of the liver during hepatic surgery. J Gastrointest Surg. 2004;8:313-327.
25. Strasberg SM; for the International Hepato-Pancreato-Biliary Association Terminology Committee Survey. The Brisbane 2000 terminology of liver anatomy and resections. HPB. 2000;2:333-339.
26. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Am Stat Assoc J. 1958;53:457-480.
27. Aloia TA, Vauthey JN, Loyer EM, et al. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg. 2006;141:460-466; discussion 466-467.
28. Nuzzo G, Giuliante F, Ardito F, et al. Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience. Surgery. 2008;143:384-393.
29. Figueras J, Burdio F, Ramos E, et al. Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections. Ann Oncol. 2007;18:1190-1195.
30. Holm A, Bradley E, Aldrete JS. Hepatic resection of metastasis from colorectal carcinoma. Morbidity, mortality, and pattern of recurrence. Ann Surg. 1989;209:428-434.
31. Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer. N Engl J Med. 2005;352:476-487.
32. Jatzko GR, Lisborg PH, Stettner HM, et al. Hepatic resection for metas-tases from colorectal carcinoma-a survival analysis. Eur J Cancer. 1995;31A:41-46.
33. Petrelli NJ, Nambisan RN, Herrera L, et al. Hepatic resection for isolated metastasis from colorectal carcinoma. Am J Surg. 1985;149:205-209.
34. Cady B, McDermott WV. Major hepatic resection for metachronous metas-tases from colon cancer. Ann Surg. 1985;201:204-209.
35. August DA, Sugarbaker PH, Ottow RT, et al. Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant intraperitoneal 5-flu-orouracil via Tenckhoff catheter on survival. Ann Surg. 1985;201:210-218.
36. de Haas RJ, Wicherts DA, Flores E, et al. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg. 2008;248:626-637.
37. Thorstensen L, Qvist H, Heim S, et al. Evaluation of 1p losses in primary carcinomas, local recurrences and peripheral metastases from colorectal cancer patients. Neoplasia. 2000;2:514-522.
38. Varghese S, Burness M, Xu H, et al. Site-specific gene expression profiles and novel molecular prognostic factors in patients with lower gastrointestinal adenocarcinoma diffusely metastatic to liver or peritoneum. Ann Surg Oncol. 2007;14:3460-3471.
39. Brachet D, Lermite E, Rouquette A, et al. Prognostic factors of survival in repeat liver resection for recurrent colorectal metastases: review of sixty-two cases treated at a single institution. Dis Colon Rectum. 2009;52:475-483.
40. Pessaux P, Lermite E, Brehant O, et al. Repeat hepatectomy for recurrent colorectal liver metastases. J Surg Oncol. 2006;93:1-7.
41. Adam R, Pascal G, Azoulay D, et al. Liver resection for colorectal metastases: the third hepatectomy. Ann Surg. 2003;238:871-883; discussion 883-884.